echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Cell Rep: The role of brain proteins in movement disorders in children

    Cell Rep: The role of brain proteins in movement disorders in children

    • Last Update: 2022-11-15
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
          

       

    Image: Structural proteins (neurofilaments, yellow) aggregate
    in the ARSACS mouse cerebellum due to knockout of the sacin gene.


    Scientists at the University of North Carolina School of Medicine and the University of North Carolina Escherman School of Pharmacy, they collaborated with the team at Queen Mary University of London to elucidate the molecular events
    of a genetic motor and neurodegenerative disease known as ARSACS.
    ARSACS is an autosomal recessive spastic ataxia of Charlevoix-Saguenay, named
    after the two Quebec valleys where the first case was found.

    Children with ARSACS usually show difficulty walking at the age of two, after which they develop a series of neurological problems
    .
    The cerebellum is the area of the brain that coordinates movement and balance, and in individuals with ARSACS, a type of neuron called Purkinje cell dies
    .
    Most patients have to use a wheelchair between the ages of 30 and 40, and the average life expectancy is shortened
    by the age of 55.

    The disease is caused by genetic mutations and loss of function in the capsule, which encodes a very large protein called capsule protein, which has been difficult to study
    directly due to its large size.
    Relatively little
    is known about its normal function and how its absence causes disease.
    In the United States, the collaborating researchers conducted the most comprehensive analysis
    of what happens inside cells when cyst proteins are missing.

    "We're trying to take an unbiased approach to understanding what goes wrong
    when cells lose their cyst proteins.
    " Our findings suggest that the death of Purkinje cells in ARSACS may be due to changes in neuronal connections and synaptic structure," said study co-senior author Justin Wolter, PhD, a postdoctoral researcher
    at the University of North Carolina Center for Neuroscience.

    Another senior co-author of the study is Dr
    Paul Chapple, professor of molecular cell biology at Queen Mary University of London.

    The study began when teams at Chappell's lab and the University of North Carolina at Chapel Hill worked
    without each other's knowledge.
    "This project was initiated by Tammy Havener of the University of North Carolina's Escherman School of Pharmacy, and then joined by three postdoctoral researchers from different departments at the University of North Carolina — Wen Aw, Katherine Hixson, and myself," Wolter said
    .
    "When we realized that Lisa Romano of Chappell's lab had made similar discoveries in a different way, we all decided to join forces and move forward
    together.
    I think this is a great example of how open science and collaboration can pay off
    for the community.

    In this study, the researchers used several omics-based techniques in cultured human cells to detect how the loss of cyst protein alters protein levels and cell organization
    .
    They confirmed the presence of defects that had been noted in previous studies, such as abnormal aggregation of fibrous-forming structural proteins, defects in mitochondrial count, and dynamics, both of which are often observed
    in many neurodegenerative diseases.

    But they also found many anomalies
    that had not been discovered before.
    These include an excess of a protein called tau protein, a trajectory
    of intracellular transport regulated by tau, and changes in microtubule dynamics.
    The researchers found that the consequence of this change in transport is that many proteins cannot reach their proper locations
    within the cell.
    Of particular concern are the "synaptic adhesion" protein, which helps neurons form and maintain synapses—the connections
    between neurons that send signals.
    Consistent with these observations, the team found changes
    in synaptic structure in a mouse model of ARSACS.
    Importantly, these changes occur before
    neurodegeneration occurs.

    These findings expand the picture of how cyst proteins regulate a variety of cellular processes
    .
    They also raised the possibility that Purkinje cells — the
    most affected neurons in ARSACS — may have died due to a lack of connectivity to other neurons.
    The researchers will continue to conduct more in-depth research into these changes in the brain to understand whether this neurodegenerative disease originates from the process
    of brain development.

    The researchers note that while ARSACS may only affect a few thousand people worldwide, such research could have broader implications
    .

    "There seems to be a lot of overlap between ARSACS and other brain diseases," Chapple said
    .
    "For example, we show that in cells lacking cystin, tau protein biology is disrupted, and of course, tau protein abnormalities are also a well-known feature of
    Alzheimer's disease.
    " So we thought that studying this rare neurological disease could provide insights
    into more common diseases.

    "There's a lot of work to be done
    to understand the mechanisms by which synaptic connectivity is affected, and whether it causes neuronal death," Wolter said.
    "However, if that's the case, it could inform future treatments
    .
    "

    The article Multi-omic profiling reveals the ataxia protein sacsin is required for integrin trafficking and synaptic organization


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.